Method for detecting CAR-T (Chimeric Antigen Receptor-T) cells by combining microfluidics and immunofluorescence
By combining immunomagnetic bead enrichment with microfluidic chip partitioning and three-channel fluorescent labeling, the problem of insufficient sensitivity and operational complexity in detecting CAR-T cell concentration in vivo has been solved, achieving highly sensitive quantitative analysis of CAR-T cells and supporting precise management of CAR-T cell therapy.
Patent Information
- Application Number
- CN202511964979.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-24
- Publication Date
- 2026-02-27
AI Technical Summary
Existing methods for detecting CAR-T cell concentration in vivo are not sensitive enough, are complicated to operate, and lack unified monitoring standards and threshold settings, which limits the precision management and personalized treatment optimization of CAR-T cell therapy.
CAR-T cells were isolated from blood samples using immunomagnetic bead enrichment and microfluidic chip partitioning. Then, three-channel fluorescent labeling with labeled antigens, anti-TCR-PE, and DAPI was performed to achieve automated quantitative analysis of immunofluorescence imaging.
It achieves highly sensitive quantitative analysis of CAR-T cell number, cell morphology and function, with a detection limit of 0.001%, supporting the precision management of CAR-T cell therapy.